Publication | Closed Access

Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5

Breast OncologyMedicineClinical TrialsGynecologyFour-year ResultsBreast CancerPharmacotherapyAdjuvant TherapyOncologyRadiation OncologyCancer ResearchEndocrine-related CancerTrial 5Health Sciences